On July 9, 2024, Aspira Women's Health Inc. closed the transaction. The company issued an aggregate of 1,248,529 shares of its common stock and accompanying warrants to purchase an equal number of shares of common stock at a price of $1.53 per share and accompanying warrant for the gross proceeds of $1,910,249. The transaction included participation from from certain existing shareholders and company insiders.